Hikma Names Executive Chairman Said Darwazah as CEO After Mishlawi Departs
The move follows trimmed growth guidance after delays at a new Ohio injectables plant squeezed margins.
Overview
- Hikma said chief executive Riad Mishlawi left by mutual agreement and is retiring after more than two decades at the company.
- Executive chairman and former chief Said Darwazah assumed CEO responsibilities with immediate effect.
- The company kept 2025 guidance but warned injectables margins will be pressured by slower ramp-up at its new Ohio manufacturing site.
- Hikma now expects revenue growth at the lower end of its 6%–8% target and sees core operating profit at the lower end of guidance, about $730m–$750m.
- Shares are down nearly 25% year to date and fell on the update, with full-year 2025 results scheduled for 26 February 2026.